Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Germinal Peptide Eye Drops in Healthy Volunteers
NCT03662971Phase 1Completed
- Sponsor
- Zhaoke Ophthalmology
- Start
- Oct 2018
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of germinal peptide in Corneal epithelial defect (8 arms), sponsored by Zhaoke Ophthalmology. Started Oct 2018; status: completed.
02
Drugs
germinal peptide
03
Conditions
Corneal epithelial defect
Beyond the preview
Go deeper on NCT03662971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03662971.